Breaking News, Collaborations & Alliances

BioCision and Cook Ink Deal

Will combine technologies to standardize cell cryopreservation in closed-system vials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioCision LLC has entered into an exclusive partnership with Cook Regentec to develop two custom CoolCell controlled-rate cell freezing systems for Cook’s closed-system cell therapy CellSeal vials. Cook selected BioCision’s proprietary CoolCell technology for its effectiveness in standardizing the freezing of cells and cellular therapies such as stem cells and tissue samples that can be used in a wide range of applications from diabetes research to organ transplants. The company said the ease...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters